Consolidated Statements of Operations (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Revenue	$ 0	$ 0
General and administrative (including stock-based compensation (Note 7))	6,363,111	6,337,947
Research and development (including stock-based compensation (Note 7))	161,541	636,620
Total operating expenses	6,524,652	6,974,567
Loss from operations	(6,524,652)	(6,974,567)
Other expense (income):
Interest expense	68,185	28,833
Interest income	(2,161)	(5,263)
Gain on extinguishment of liabilities (Note 8)	(125,796)
	(59,772)	23,570
Net loss	(6,464,880)	(6,998,137)
Net loss attributable to the noncontrolling interest	17,036	5,748
Net loss attributable to Bion	(6,447,844)	(6,992,389)
Conversion inducement (Note 7)	(755,258)
Dividends on preferred stock	(155,175)	(556,375)
Net loss applicable to Bion's common stockholders	$ (7,358,277)	$ (7,548,764)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.48)	$ (0.61)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	15,436,388	12,366,062